AAAAAA

   
Results: 1-8 |
Results: 8
Angiotensin II antagonists for hypertension: There are differences in efficacy
Authors: Meredith, P Trenkwalder, P
Citation: P. Meredith et P. Trenkwalder, Angiotensin II antagonists for hypertension: There are differences in efficacy, AM J HYPERT, 14(4), 2001, pp. 394-395
Evolving strategies in cardiovascular care: The renin-angiotensin system and the future - Discussion
Authors: McMurray, J Shepherd, J Hobbs, R Swedberg, K Meredith, P
Citation: J. Mcmurray et al., Evolving strategies in cardiovascular care: The renin-angiotensin system and the future - Discussion, HEART, 84, 2000, pp. I50-I50
Scientific writing
Authors: Meredith, P
Citation: P. Meredith, Scientific writing, SCIENTIST, 14(2), 2000, pp. 6-6
Achieving quality 24-h blood pressure control with candesartan cilexetil
Authors: Meredith, P
Citation: P. Meredith, Achieving quality 24-h blood pressure control with candesartan cilexetil, BLOOD PRESS, 9, 2000, pp. 23-26
Pain in the leg
Authors: Meredith, P
Citation: P. Meredith, Pain in the leg, NEW SCI, 165(2225), 2000, pp. NIL_1-NIL_1
The NHS patient information lottery: it is whom you see rather than what you need
Authors: Meredith, P Emberton, M
Citation: P. Meredith et M. Emberton, The NHS patient information lottery: it is whom you see rather than what you need, ANN RC SURG, 82(3), 2000, pp. 217-222
Clinical pharmacokinetics of doxazosin in a controlled-release gastrointestinal therapeutic system (GITS) formulation
Authors: Chung, M Vashi, V Puente, J Sweeney, M Meredith, P
Citation: M. Chung et al., Clinical pharmacokinetics of doxazosin in a controlled-release gastrointestinal therapeutic system (GITS) formulation, BR J CL PH, 48(5), 1999, pp. 678-687
Do pharmacologic differences among antihypertensive agents point to clinical benefits?
Authors: Meredith, P
Citation: P. Meredith, Do pharmacologic differences among antihypertensive agents point to clinical benefits?, AM J CARD, 84(10A), 1999, pp. 22S-27S
Risultati: 1-8 |